Year: 2021

news_6

Dr. Reddy’s Laboratories Announces Entry Into Definitive Agreement with BioDelivery Sciences International, Inc., to Sell its U.S. and Canada Territory Rights for ELYXYB (celecoxib oral solution) 25 mg/mL

HYDERABAD, India & PRINCETON, N.J.--(BUSINESS WIRE)--Dr. Reddy’s Laboratories Limited (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY, hereafter known as...

news_6

Chiyoda Corporation and GridBeyond sign an MoU to Advance the Transition of the Japanese Electricity Sector and Create New Revenue Opportunities for I&C Businesses

LONDON & TOKYO--(BUSINESS WIRE)--#BusinessExpansion--Chiyoda Corporation (Chiyoda) and GridBeyond are pleased to announce that they have signed a Memorandum of Understanding...

news_6

Asia-Pacific Cell Therapy Market Analysis Report 2021-2028 by Use-type (Clinical-use, Research-use), & Therapy Type (Autologous, Allogeneic) – ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Asia Pacific Cell Therapy Market Size, Share & Trends Analysis Report by Use-type (Clinical-use, Research-use), by Therapy Type...